Optos Plc is a retinal imaging company. The Company�s medical devices produce ultra-widefield, high resolution digital images of approximately 82% of the retina in a single capture. The images provide enhanced clinical information for ophthalmic professionals, facilitating the early detection, management and treatment of both eye and non-eye disorders and diseases that may exhibit in the retina. The Company�s widefield retinal imaging technology, combined with the specific data that can be derived from optical coherence tomography (OCT) images, has the potential to offer ophthalmologists and optometrists the tools for disease diagnosis and management. The optomap images provide enhanced clinical information, which facilitates the early detection, management and treatment of disorders and diseases evidenced in the retina, such as retinal detachments and tears, glaucoma, diabetic retinopathy and age-related macular degeneration.